drugset / Trial / NCT00321477
A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a Phase IIa study to evaluate the efficacy, safety and tolerability of GW679769 vs placebo on symptoms of urgency with urge incontinence, frequency and nocturia associated with overactive bladder in women.
Timeline
- Start
- 2005-12
- Primary completion
- 2007-02
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Casopitant | Small molecule | 60 mg | Oral |
| Subject | Casopitant | Small molecule | 120 mg | Oral |